Moreover, the endogenous TRAIL signaling pathway can recruit immunosuppressive TAMs by inducing tumor cells to secrete the cytokine CCL2, promoting an immunosuppressive microenvironment and inhibiting cytotoxic T lymphocyte (CTL) activation [19]. This evidence concerns the gene CCL2 and neoplasm.